Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2019-03-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
内部控制规则落实自查表
Regulatory Filings Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to internal audit, information disclosure, insider trading controls, fundraising, related party transactions, external guarantees, major investments, and other important matters. The document is a self-assessment or compliance checklist rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory announcements. It is not a report publication announcement or certification letter but rather an internal control compliance document. Such documents typically fall under Regulatory Filings (RNS) as they are compliance-related disclosures that do not fit into other specific categories like Annual Report, Audit Report, or Earnings Release.
2019-03-20 Chinese
关于2018年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2018 annual profit distribution plan of a company, including details about dividends, board and supervisory committee approvals, and independent director opinions. It does not contain full financial statements or comprehensive financial performance data but rather focuses on the dividend distribution proposal and related approvals. The document length is 2396 characters, which is relatively short and typical for an announcement rather than a full report. It is not an annual report (10-K), interim report, or earnings release. It is specifically about the dividend distribution plan, which fits the category of Notice of Dividend Amount (DIV).
2019-03-20 Chinese
独立董事关于第三届董事会第十三次会议相关事项的独立意见
Governance Information Classification · 95% confidence The document is an independent director's opinion on various company matters related to the 2018 fiscal year, including profit distribution, internal control self-evaluation, use of raised funds, external guarantees, related party transactions, and investment project delays. It references compliance with laws and regulations, and provides detailed independent opinions on these topics. The document is not a full annual report but rather a formal independent opinion report related to governance and compliance matters typically presented to shareholders or regulators. It does not contain full financial statements or earnings data, nor is it a brief announcement or a certification letter. Given the focus on governance, internal controls, and compliance, this fits best under the category of Governance Information (CGR). The document length is 3145 characters, which is relatively short but contains substantive content beyond a mere announcement or certification, supporting the CGR classification rather than RPA or RNS.
2019-03-20 Chinese
关于公司募集资金年度存放与实际使用情况的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (verification report) regarding the annual deposit and actual use of raised funds by 葵花药业集团股份有限公司 (Sunflower Pharmaceutical Group Co., Ltd.) for the year ending December 31, 2018. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange concerning the management and use of raised funds. The document includes detailed tables on the use of raised funds, changes in investment projects, and compliance with disclosure requirements. It is a specialized audit or attestation report on the use of capital raised by the company, not a full annual or interim financial report. The document is about the verification of the use of fundraising proceeds, which fits the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or Capital/Financing Update (CAP). The length (7,822 characters) and content indicate it is the report itself, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2018
2019-03-20 Chinese
第三届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 13th meeting of the third board of directors of a company, including approval of the 2018 annual report, financial statements, profit distribution plan, internal control reports, and other corporate governance matters. It references the 2018 annual report and financial results but does not contain the full annual report itself. It also includes voting results and mentions that these matters will be submitted to the 2018 annual general meeting for approval. The document is a formal board meeting resolution announcement, not the annual report itself. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management information.
2019-03-20 Chinese
2018年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for the fiscal year ending December 31, 2018, issued by 瑞华会计师事务所 (Ruihua Certified Public Accountants). It contains detailed audit opinions, basis for audit, key audit matters, management responsibilities, and the auditor's responsibilities. It also includes comprehensive financial statements such as consolidated balance sheets, income statements, cash flow statements, and statements of changes in equity, along with extensive notes to the financial statements. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of detailed audit opinions and full financial statements confirms this is a standalone audit report, not the full annual report or a certification letter. Therefore, the correct classification is Audit Report / Information (AR). FY 2018
2019-03-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.